These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26316756)

  • 1. Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain.
    Ogawa K; Fujikoshi S; Montgomery W; Alev L
    Neuropsychiatr Dis Treat; 2015; 11():2101-7. PubMed ID: 26316756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial.
    Wernicke JF; Raskin J; Rosen A; Pritchett YL; D'Souza DN; Iyengar S; Knopp K; Le TK
    Curr Ther Res Clin Exp; 2006 Sep; 67(5):283-304. PubMed ID: 24678103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes.
    Armstrong DG; Chappell AS; Le TK; Kajdasz DK; Backonja M; D'Souza DN; Russell JM
    Pain Med; 2007; 8(5):410-8. PubMed ID: 17661854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin.
    Enomoto H; Yasuda H; Nishiyori A; Fujikoshi S; Furukawa M; Ishida M; Takahashi M; Tsuji T; Yoshikawa A; Alev L
    J Pain Res; 2018; 11():1857-1868. PubMed ID: 30271191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
    Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
    Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain.
    Skljarevski V; Frakes EP; Sagman D; Lipsius S; Heinloth AN; Dueñas Tentori HJ
    Pain Res Treat; 2012; 2012():898347. PubMed ID: 22973509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.
    Vinik A; Emir B; Cheung R; Whalen E
    Clin Ther; 2013 May; 35(5):612-23. PubMed ID: 23541708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the correlation and responsiveness of patient-reported pain with function and quality-of-life outcomes after spine surgery.
    DeVine J; Norvell DC; Ecker E; Fourney DR; Vaccaro A; Wang J; Andersson G
    Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S69-74. PubMed ID: 21897347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA; Hall JA; Risser RC; Gonzales JS
    Pain Pract; 2009; 9(5):354-62. PubMed ID: 19500272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
    Arnold LM; Pritchett YL; D'Souza DN; Kajdasz DK; Iyengar S; Wernicke JF
    J Womens Health (Larchmt); 2007 Oct; 16(8):1145-56. PubMed ID: 17937567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
    Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
    Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurately measuring the quality and effectiveness of cervical spine surgery in registry efforts: determining the most valid and responsive instruments.
    Godil SS; Parker SL; Zuckerman SL; Mendenhall SK; McGirt MJ
    Spine J; 2015 Jun; 15(6):1203-9. PubMed ID: 24076442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
    Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
    J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
    Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
    Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study.
    McInnes IB; Mease PJ; Schett G; Kirkham B; Strand V; Williams N; Fox T; Pricop L; Jugl SM; Gandhi KK;
    Arthritis Res Ther; 2018 Jun; 20(1):113. PubMed ID: 29880010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA; Hall J; Meyers AL; Gonzales J; Mallinckrodt C
    J Pain Symptom Manage; 2008 Dec; 36(6):639-47. PubMed ID: 18504092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
    Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
    Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    Wu EQ; Birnbaum HG; Mareva MN; Le TK; Robinson RL; Rosen A; Gelwicks S
    J Pain; 2006 Jun; 7(6):399-407. PubMed ID: 16750796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.